Digital Content 
NEWS #PharmaBuzz
08 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/08/3146157/15991/en/New-4-Year-Data-for-Pombiliti-cipaglucosidase-alfa-atga-Opfolda-miglustat-Presented-at-ICIEM.html
04 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/04/3144382/16626/en/Zevra-Therapeutics-Presents-Positive-New-Data-Supporting-Foundational-Role-of-MIPLYFFA-arimoclomol-for-the-Treatment-of-Niemann-Pick-Disease-Type-C-at-the-International-Congress-of.html
25 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/25/3104947/15991/en/Amicus-Therapeutics-Announces-Approval-of-Pombiliti-cipaglucosidase-alfa-Opfolda-miglustat-in-Japan.html
03 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/03/3092575/15991/en/New-Analysis-of-Pombiliti-cipaglucosidase-alfa-atga-Opfolda-miglustat-Published-in-Muscle-and-Nerve.html
04 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/04/2892922/15991/en/Amicus-Therapeutics-Receives-Prix-Galien-U-K-Award-for-Pombiliti-cipaglucosidase-alfa-Opfolda-miglustat-as-Best-Pharmaceutical-Product.html
01 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/pantherxrare-selected-by-edenbridge-pharmaceuticals-as-specialty-pharmacy-for-yargesa-miglustat-100-mg-capsules-302104863.html
Share 